MAPT and amyloidosis: An excellent selectivity was alsoobtained toward the Aβ1–42 peptide which approachesan excellent assessment of amyloidosis in the human brain, as demonstratedby the good correlation obtained (r = 0.97) between the quantitativelevels obtained in our microswimmers approach in comparison with theenzyme-linked immunosorbent assay method in diagnosed CSF samplesfrom patients where Tau protein was also determined due to its coexistencewith Aβ1–42 peptides.